» Articles » PMID: 33396834

MicroRNAs and Sepsis-Induced Cardiac Dysfunction: A Systematic Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 5
PMID 33396834
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is a severe condition characterized by systemic inflammation. One of the most involved organs in sepsis is the heart. On the other hand, heart failure and dysfunction are some of the most leading causes of death in septic patients. miRNAs are short single-strand non-coding ribonucleic acids involved in the regulation of gene expression on a post-transcriptional phase, which means they are a part of the epigenetic process. Recently, researchers have found that miRNA expression in tissues and blood differs depending on different conditions. Because of this property, their use as serum sepsis biomarkers has also been explored. A narrative review is carried out to gather and summarize what is known about miRNAs' influence on cardiac dysfunction during sepsis. When reviewing the literature, we found at least 77 miRNAs involved in cardiac inflammation and dysfunction during sepsis. In the future, miRNAs may be used as early sepsis-induced cardiac dysfunction biomarkers or as new drug targets. This could help clinicians to early detect, prevent, and treat cardiac damage. The potential role of miRNAs as new diagnostic tools and therapeutic strategies worth deepening the complex network between non-coding RNA and biological pathways. Additional studies are needed to further investigate their role in sepsis-induced myocardium injury.

Citing Articles

Postmortem analyses of myocardial microRNA expression in sepsis.

Lehto P, Skarp S, Saukko T, Sakkinen H, Syrjala H, Kerkela R Sci Rep. 2024; 14(1):29476.

PMID: 39604475 PMC: 11603066. DOI: 10.1038/s41598-024-81114-6.


miR-361-3p overexpression promotes apoptosis and inflammation by regulating the USP49/IκBα/NF-κB pathway to aggravate sepsis-induced myocardial injury.

Geng H, Qi L, You L, Feng W, Yang X, Lei M Toxicol Res (Camb). 2024; 13(6):tfae190.

PMID: 39568464 PMC: 11574052. DOI: 10.1093/toxres/tfae190.


Time of day-dependent alterations of ferroptosis in LPS-induced myocardial injury via Bmal-1/AKT/ Nrf2 in rat and H9c2 cell.

Ying-Hao P, Yu-Shan Y, Song-Yi C, Hua J, Peng Y, Xiao-Hu C Heliyon. 2024; 10(17):e37088.

PMID: 39296207 PMC: 11407985. DOI: 10.1016/j.heliyon.2024.e37088.


COVID-19: from immune response to clinical intervention.

Guo Z, Tang Y, Zhang Z, Liu J, Zhuang Y, Li T Precis Clin Med. 2024; 7(3):pbae015.

PMID: 39139990 PMC: 11319938. DOI: 10.1093/pcmedi/pbae015.


Septic Cardiomyopathy.

Lukic I, Mihic D, Canecki Varzic S, Relatic K, Zibar L, Loinjak D Rev Cardiovasc Med. 2024; 25(1):23.

PMID: 39077653 PMC: 11262393. DOI: 10.31083/j.rcm2501023.


References
1.
Hobai I, Edgecomb J, LaBarge K, Colucci W . Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy. Shock. 2014; 43(1):3-15. PMC: 4269564. DOI: 10.1097/SHK.0000000000000261. View

2.
An R, Feng J, Xi C, Xu J, Sun L . miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression. Oxid Med Cell Longev. 2018; 2018:7163057. PMC: 6129849. DOI: 10.1155/2018/7163057. View

3.
Chen T, Zhu C, Ye C . LncRNA CYTOR attenuates sepsis-induced myocardial injury via regulating miR-24/XIAP. Cell Biochem Funct. 2020; 38(7):976-985. DOI: 10.1002/cbf.3524. View

4.
Wang H, Bei Y, Shen S, Huang P, Shi J, Zhang J . miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. J Mol Cell Cardiol. 2016; 94:43-53. DOI: 10.1016/j.yjmcc.2016.03.014. View

5.
Wang H, Meng K, Chen W, Feng D, Jia Y, Xie L . Serum miR-574-5p: a prognostic predictor of sepsis patients. Shock. 2012; 37(3):263-7. DOI: 10.1097/SHK.0b013e318241baf8. View